Title of article
Adjuvant Drugs for Peripheral Nerve Blocks: The Role of NMDA Antagonists, Neostigmine, Epinephrine, and Sodium Bicarbonate
Author/Authors
Edinoff ، Amber N. Department of Psychiatry and Behavioral Medicine - Health Science Center Shreveport - Louisiana State University , Fitz-Gerald ، Joseph S. Department of Psychiatry and Behavioral Medicine - Health Science Center Shreveport - Louisiana State University , Holland ، Krisha Andrea A. Department of Physical Therapy - School of Allied Health - Louisiana State University Shreveport , Reed ، Johnnie G. Department of Physical Therapy - School of Allied Health - Louisiana State University Shreveport , Murnane ، Sarah E. Department of Physical Therapy - School of Allied Health - Louisiana State University Shreveport , Minter ، Sarah G. Department of Physical Therapy - School of Allied Health - Louisiana State University Shreveport , Kaye ، Aaron J. Department of Anesthesiology and Perioperative Medicine - Medical University of South Carolina , Cornett ، Elyse M. Department of Anesthesiology - Louisiana State University Shreveport , Imani ، Farnad Department of Anesthesiology and Pain Medicine - Pain Research Center - Iran University of Medical Sciences , Khademi ، -Hossein Department of Anesthesiology - Mashhad University of Medical Sciences , Kaye ، Adam M. Department of Pharmacy Practice - Thomas J. Long School of Pharmacy and Health Sciences - University of the Pacific , Urman ، Richard D. Department of Anesthesiology, Perioperative and Pain Medicine - Brigham and Women’s Hospital , Kaye ، Alan D. Department of Anesthesiology - Louisiana State University Shreveport
From page
1
To page
0
Abstract
The potential for misuse, overdose, and chronic use has led researchers to look for other methods to decrease opioid consumption in patients with acute and chronic pain states. The use of peripheral nerve blocks for surgery has gained increasing popularity as it minimizes peripheral pain signals from the nociceptors of local tissue sustaining trauma and inflammation from surgery. The individualization of peripheral nerve blocks using adjuvant drugs has the potential to improve patient outcomes and reduce chronic pain. The major limitations of peripheral nerve blocks are their limited duration of action and dosedependent adverse effects. Adjuvant drugs for peripheral nerve blocks show increasing potential as a solution for postoperative and chronic pain with their synergistic effects to increase the duration of action and decrease the required dosage of local anesthetic. N-methyl-d-aspartate (NMDA) receptor antagonists are a viable option for patients with opioid resistance and neuropathic pain due to their affinity to the neurotransmitter glutamate, which is released when patients experience a noxious stimulus. Neostigmine is a cholinesterase inhibitor that exerts its effect by competitively binding at the active site of acetylcholinesterase, which prevents the hydrolysis of acetylcholine and subsequently retaining acetylcholine at the nerve terminal. Epinephrine, also known as adrenaline, can potentially be used as an adjuvant to accelerate and prolong analgesic effects in digital nerve blocks. The theorized role of sodium bicarbonate in local anesthetic preparations is to increase the pH of the anesthetic. The resulting alkaline solution enables the anesthetic to more readily exist in its unionized form, which more efficiently crosses lipid membranes of peripheral nerves. However, more research is needed to show the efficacy of these adjuvants for nerve block prolongation as studies have been either mixed or have small sample sizes.
Keywords
Peripheral Nerve Blocks , NMDA Antagonists , Adjuvants , Neostigmine , Bicarbonate , Epinephrine
Journal title
Anesthesiology and Pain Medicine
Journal title
Anesthesiology and Pain Medicine
Record number
2762437
Link To Document